Locks in. Stays intact.

Kills microbes.*
• Exufiber® Ag+ is a non-woven PVA dressing that
transforms into a gel upon contact with exudate,
helping it to softly conform to the wound bed1,2
• High structural integrity enabling one-piece
dressing removal3,4
• Absorbs and locks in exudate, blood
and bacteria4–8
• High retention capacity to prevent leakage
and maceration4,5
• Controlled release of silver ions within the
dressing when in contact with wound fluid,
providing antimicrobial action for up to 7 days
(in vitro)9

High structural integrity

• Enables one-piece dressing removal3,4
• Reduces the risk of residue and fibers
being left in the wound3,4,10

High lock-in capacity

• Reduces the risk of leakage4,5
• Reduces the risk of maceration11,12
• Absorbs and locks in exudate,
bacteria and blood4–8

Polyvinyl alcohol (PVA)

dressing incorporating patented Sustained antimicrobial action
Hydrolock® Technology with silver sulphate
• Highly absorbent, even under compression6 • Kills a broad range of pathogens
• Soft and conformable, making it easy to apply1,2 (in vitro)14
• Locks in exudate, minimizing risk of leakage • Keeps its antimicrobial effect
and maceration4,5 for up to 7 days (in vitro)14
• Can be left in place for up to 7 days

Combining Hydrolock® Technology and silver

 Locks in exudate to reduce the How to use Exufiber® Ag+
risk of leaks and maceration4,5 1. Cleanse the wound with saline
solution or water according
Exufiber Ag+ is highly absorbent, even under compression. 6

to clinical practice. Dry the

The Hydrolock Technology enables the dressing to absorb and
surrounding skin thoroughly.
retain exudate, blood, and bacteria, preventing leakage and
Remove dressing aseptically from
maceration. 4–8, 11, 12
the packaging.

2. A
 pply a dry Exufiber Ag+ dressing
Stays intact for clean and easy, to the wound. The dressing should

one-piece removal3,4 be able to cover the entire wound.

It should overlap the dry
The Hydrolock Technology provides Exufiber Ag+ with high wet tensile surrounding skin by at least 1–2
strength to enable dressing removal in one piece. 3,4 cm for the smaller sizes and 5 cm
for larger sizes. The dressing will
shrink as it absorbs wound fluid
and starts gelling.
Rapid and sustained
antimicrobial effect14 3. Loosely pack ribbon or sheet into
Exufiber Ag+ contains silver sulphate that is evenly distributed in the the wound to allow room for
dressing. Contact with wound fluid initiates a rapid and sustained swelling of the dressing.
antimicrobial effect within the dressing against wound-relevant
pathogens. Exufiber Ag+ kills a broad range of pathogens including
4. F
 ixate with an appropriate
VRE, MRSA and fungi as shown in vitro. 13
secondary dressing. Compression
therapy may be used in
conjunction with Exufiber Ag+.

Exufiber® Ag+ ordering information

Product Code Size Pcs/box Pcs/case HCPCS
Intended use
603421 2˝ x 2˝ (5 x 5 cm) 10 40 A6196
Exufiber Ag+ is intended to be used in the following medium to high exuding wounds:
603422 4˝ x 4.8˝ (10 x 12 cm) 10 60 A6197 • Leg ulcers (venous stasis ulcers, arterial ulcers and ulcers
603423 6˝ x 6˝ (15 x 15 cm) 10 60 A6197
of mixed etiology) and diabetic foot ulcers
• Pressure ulcers (partial and full thickness)
603424 8˝ x 12˝ (20 x 30 cm) 5 20 A6198 • Partial thickness burns (second degree)
603420 0.8˝ x 17.7˝ (2 x 45 cm) 5 20 A6199 • Donor sites and other wounds that are prone to bleeding,
such as debrided wounds (mechanically or surgically)
• Traumatic wounds
Exufiber® (Non Ag) ordering information
• Surgical wounds that heal by primary intention, such as dermatological and
Product Code Size Pcs/box Pcs/case HCPCS surgical incisions (e.g. orthopedic and vascular), and surgical wounds left to heal by
secondary intention, such as dehisced surgical incisions
709900 2˝ x 2˝ (5 x 5 cm) 10 40 A6196
• Oncology wounds with exudate, such as fungoides-cutaneous tumors, fungating
709902 4˝ x 4.8˝ (10 x 12 cm) 10 60 A6197 carcinoma, cutaneous metastasis, Kaposi’s sarcoma and angiosarcoma
709903 6˝ x 6˝ (15 x 15 cm) 10 60 A6197

709909 0.8˝ x 17.7˝ (2 x 45 cm) 5 25 A6196

References: 1. Davies P, McCarty S. An in-use product evaluation of a gelling fiber dressing in wound management. E-poster presentation at Wounds UK Conference, 2017, Harrogate, United Kingdom. 2. Lev-Tov et al. An interim
analysis of clinical investigation to evaluate exudate management and comfort of use of an antimicrobial gelling fiber dressing* in medium to highly exudative wounds. Poster presented at the Symposium of Advanced Wound Care,
Fall meeting 2018, Las Vegas, NV, USA. 3. Mölnlycke Health Care Laboratory Report PD-521248 (data on file). 4. Mölnlycke Health Care Laboratory Report PD-556978 (data on file). 5. Mölnlycke Health Care Laboratory Report PD-
520425 (data on file). 6. Mölnlycke Health Care Laboratory Report PD-521232 (data on file). 7. Mölnlycke Health Care Laboratory Report PD-522900 (data on file). 8. Mölnlycke Health Care Laboratory Report PD- 521245 (data on
file). 9. Hamberg K et al. Antimicrobial effect of a new silver-containing gelling fiber dressing against common wound pathogens. Poster presented at the Symposium on Advanced Wound Care Spring meeting/Wound Healing
Society (WHS) Annual Meeting 2017, Apr 05–09, 2017, San Diego, CA, USA. 10. Mölnlycke Health Care Laboratory Report PD- 522908 (data on file). 11. Open, non-comparative, multi-centre post marketing clinical follow-up
investigation to evaluate performance and safety on diabetic Foot Ulcer, DFU, when using EXUFIBER as intended, Clinical Investigation Report PD-485206 rev.01. 12. Open, non-comparative, multi-centre post market clinical
follow-up investigation to evaluate performance and safety on pressure ulcers, PU, when using Exufiber as intended, Clinical Investigation Report PD-492923 rev.00. 14. Hamberg K et al. Antimicrobial effect of a new silver-
containing gelling fiber dressing against common wound pathogens. Poster presented at the Symposium on Advanced Wound Care Spring meeting/Wound Healing Society (WHS) Annual Meeting 2017, Apr 05–09, 2017, San Diego,
CA, USA. *In-vitro testing demonstrates that Exufiber Ag+ kills a wide range of known wound pathogens and creates an antimicrobial environment within the dressing

Find out more at www.molnlycke.us/ExufiberAgPlus

The Mölnlycke and Exufiber trademarks, names and logo types are registered globally to one or more of the Mölnlycke Health Care Group of Companies.
Distributed by Mölnlycke Health Care US, LLC, Norcross, Georgia 30092. © 2019  Mölnlycke Health Care AB.  All rights reserved. 1-800-843-8497. MHC-2019-37860

USMM 270547 03.20